EUCTR2006-001272-21-IT进行中（未招募）不适用
Phase II trial of second line therapy with Oxaliplatin and Pemetrexed in patients with advanced pancreatic cancer - Pemetrexed_Oxaliplatino
AZIENDA OSPEDALIERO-UNIVERSITARIA S. MARIA DELLA MISERICORDIA DI UDINE0 个研究点开始时间: 2007年5月24日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •1. written informed consent; 2. Histological diagnosis of pancreatic cancer; 3. Advanced disease; 4. At least one measurable lesion (RECIST criteria); 5. Age 18-70 6. ECOG 0-1; 7. Adequate bone marrow, epatic and renal function; 8. Progressive disease to previous chemotherapy with Gemcitabine.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range: 0
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •1. Previous chemotherapy containing Pemetrexed or Oxaliplatin; 2. Previous or concomitant cancers, except curatively treated cervical carcinoma in situ or non-melanoma skin cancer; 3. Pregnant or lactating women; 4. Peripheral Neuropathy grade >2; 5. concomitant treatment with other sperimental drugs; 6. Medical controindications to chemotherapic treatment.
研究者
相似试验
未知
2 期
Phase II clinical study on combination of oxaliplatin (L-OHP) and S-1 in advanced / recurrent gastric cancer untreated with chemotherapyGastric cancerJPRN-jRCT2080220365Yakult Honsha Co.,Ltd.
已完成
2 期
Phase II clinical trial on systemic oxaliplatin chemotherapy plus molecular target therapy combined with hepatic arterial infusion (HAI) therapy for colorectal liver metastasesColorectal cancerJPRN-UMIN000019466Department of Gastroenterological Surgery, Tokai University School of Medicine47
已完成
2 期
Phase II trial of combination therapy with oxaliplatin and capecitabine in patients with advanced oesophageal cancerCancerISRCTN07447845Erasmus Medical Centre (The Netherlands)51
已完成
2 期
A phase II study of Oxaliplatin Reintroduction in patients pretreated with Oxaliplatin and Irinotecan for Advanced Colorectal CancerMetastatic colorectal cancerJPRN-UMIN000004884Japanese foundation for cancer research33
进行中（未招募）
1 期
Multicentre phase 2 study of neoadjuvant oxaliplatin and capecitabine followed by chemo-radiotherapy in patients with locally advanced carcinoma of esphago-gastric junction.ocally advanced carcinoma (squamous or adenocarcinoma) of the esophago-gastric junction Siewert type I and IIMedDRA version: 14.1Level: LLTClassification code 10056267Term: Gastroesophageal cancerSystem Organ Class: 100000004864EUCTR2013-001630-18-ITIstituto Nazionale per lo Studio e la Cura dei Tumori di Napoli – Fondazione G.Pascale”40